R&D-intensive firms, especially in the pharmaceutical and ICT industries, face continuous pressure to produce new innovations and patents in order to survive and compete in the market. One of the solutions has been to lower costs by collaborating openly or partnering with other companies. However, according to Afnan Zafar’s doctoral dissertation, the cheapest way to be competitive is not always the best.